EW
Edwards Lifesciences CorporationHealthcare · $50.0B market cap
Verdict
Share price
$85.15
close of Oct 3, 2026
Fair value
$33.76
Sticker Price
Payback Price
$13.50
buy price
EW is Overpriced: at $85.15 it trades 152% above its fair value of $33.76. Its buy price (Payback Price) is $13.50, 84% below today's price. Business quality is strong: all 5 key numbers clear the 10% bar.
How we valued it
Free Cash Flow. Sales grew 4% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.
Business quality
5 of 5 clear the 10% bar. What are the Big Five?
Follow EW
Get notified when it reaches its buy price of $13.50. Free.
Create a free accountSuperinvestors
2 of the investors we track hold EW. In Q2 2026, 1 sold out. Who we track
David Rolfe
Wedgewood Partners · as of Q2 2026
$14.9M
165,208 shares
Torray Funds
Torray Funds · as of Q2 2026
$271K
2,994 shares
Moves in Q2 2026
Sold out: Viking Global Investors
Insider activity
Since Jun 17, 2026: no open-market purchases, 13 sales worth $4.6M and 13 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Lippis Daniel J.
CVP, TAVR · 2026-09-11
Sold
$54K
Dahl Andrew M.
SVP, Corporate Controller · 2026-08-31
Sold
$50K
Bruls Annette
CVP, EMEACLA · 2026-08-28
Sold
$238K
Markowitz Wayne
CVP, JAPAC · 2026-08-26
Sold
$113K
Chopra Daveen
CVP, TMTT, Surgical & IHFM · 2026-08-26
Sold
$2.8M
Show all 13 salesShow fewer
Chopra Daveen
CVP, TMTT, Surgical & IHFM · 2026-08-26
Sold
$106K
Lippis Daniel J.
CVP, TAVR · 2026-08-11
Sold
$57K
Markowitz Wayne
CVP, JAPAC · 2026-07-30
Sold
$13K
Markowitz Wayne
CVP, JAPAC · 2026-07-28
Sold
$819K
Zovighian Bernard J
CEO · 2026-07-27
Sold
$245K
Lippis Daniel J.
CVP, TAVR · 2026-07-10
Sold
$57K
Lippis Daniel J.
CVP, TAVR · 2026-06-30
Sold
$57K
Zovighian Bernard J
CEO · 2026-06-17
Sold
$46K
Other filings
Lippis Daniel J.
CVP, TAVR · 2026-09-11
Option exercise
$45K
Chopra Daveen
CVP, TMTT, Surgical & IHFM · 2026-09-11
Tax withholding
$35K
Chopra Daveen
CVP, TMTT, Surgical & IHFM · 2026-08-26
Option exercise
$2.3M
Lippis Daniel J.
CVP, TAVR · 2026-08-11
Option exercise
$45K
Markowitz Wayne
CVP, JAPAC · 2026-07-28
Option exercise
$713K
Show all 13 other filingsShow fewer
Zovighian Bernard J
CEO · 2026-07-27
G-Gift
319.65 shares
Bruls Annette
CVP, EMEACLA · 2026-07-11
Tax withholding
$10K
Lippis Daniel J.
CVP, TAVR · 2026-07-10
Option exercise
$45K
Mistras Theodora
CVP, Chief Financial Officer · 2026-07-09
Award
$5.6M
Mistras Theodora
CVP, Chief Financial Officer · 2026-07-09
Award
87,595 shares
Mistras Theodora
CVP, Chief Financial Officer · 2026-07-09
Award
12,325 shares
Lippis Daniel J.
CVP, TAVR · 2026-07-07
Tax withholding
$36K
Lippis Daniel J.
CVP, TAVR · 2026-06-30
Option exercise
$45K
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio…
Medical - Devices
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works